{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T10:44:44Z","timestamp":1782211484960,"version":"3.54.5"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:00:00Z","timestamp":1766534400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005971","name":"Deutsche Herzstiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005971","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB TRR219"],"award-info":[{"award-number":["SFB TRR219"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["322900939"],"award-info":[{"award-number":["322900939"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Talanta"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.talanta.2025.129293","type":"journal-article","created":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:07:31Z","timestamp":1766534851000},"page":"129293","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Capillary blood microsampling and LC\u2013Orbitrap analysis for adherence monitoring of cardiovascular drugs: method development, cross-validation, and patient proof-of-concept using VAMS and Capitainer-B"],"prefix":"10.1016","volume":"301","author":[{"given":"Diana","family":"Kretschmer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6059-1671","authenticated-orcid":false,"given":"Mert","family":"Tokcan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5043-8520","authenticated-orcid":false,"given":"Philipp","family":"Markwirth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7470-7912","authenticated-orcid":false,"given":"Lea","family":"Wagmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Mahfoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"B\u00f6hm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4377-6784","authenticated-orcid":false,"given":"Markus R.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"25","key":"10.1016\/j.talanta.2025.129293_bib1","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1016\/j.jacc.2022.11.001","article-title":"Global burden of cardiovascular diseases and risks collaboration, 1990-2021","volume":"80","author":"Lindstrom","year":"2022","journal-title":"JACC (J. Am. Coll. Cardiol.)"},{"issue":"13_Supplement","key":"10.1016\/j.talanta.2025.129293_bib2","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1016\/S0735-1097(24)04310-9","article-title":"Global prevalence of coronary artery disease: an update from the global burden of disease study","volume":"83","author":"Stark","year":"2024","journal-title":"JACC (J. Am. Coll. Cardiol.)"},{"issue":"9","key":"10.1016\/j.talanta.2025.129293_bib3","article-title":"AHA\/ACC\/ACCP\/ASPC\/NLA\/PCNA guideline for the management of patients with chronic coronary disease: a report of the American heart Association\/American College of Cardiology Joint Committee on clinical practice Guidelines","volume":"148","author":"Virani Salim","year":"2023","journal-title":"Circulation"},{"issue":"36","key":"10.1016\/j.talanta.2025.129293_bib4","first-page":"3415","article-title":"ESC Scientific Document Group 2024 ESC Guidelines for the management of chronic coronary syndromes: developed by the task force for the management of chronic coronary syndromes of the European Society of Cardiology (ESC)","volume":"45","author":"Christiaan","year":"2024","journal-title":"Eur. Heart J."},{"issue":"2","key":"10.1016\/j.talanta.2025.129293_bib5","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.ahj.2013.04.016","article-title":"Effects of nonpersistence with medication on outcomes in high-risk patients with cardiovascular disease","volume":"166","author":"B\u00f6hm","year":"2013","journal-title":"Am. Heart J."},{"key":"10.1016\/j.talanta.2025.129293_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1570359","article-title":"Clinical and economic consequences of medication nonadherence: a review of systematic reviews","volume":"16","author":"Achterbosch","year":"2025","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.talanta.2025.129293_bib8","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s11096-013-9869-6","article-title":"How do we better translate adherence research into improvements in patient care?","volume":"36","author":"La Caze","year":"2014","journal-title":"Int. J. Clin. Pharm."},{"issue":"6","key":"10.1016\/j.talanta.2025.129293_bib9","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.006056","article-title":"Antihypertensive medication adherence and risk of cardiovascular disease among older adults: a population-based cohort study","volume":"6","author":"Yang","year":"2017","journal-title":"J. Am. Heart Assoc."},{"issue":"22","key":"10.1016\/j.talanta.2025.129293_bib10","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1001\/jama.288.22.2868","article-title":"Interventions to enhance patient adherence to medication prescriptions: scientific review","volume":"288","author":"McDonald","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.talanta.2025.129293_bib11","series-title":"Opportunities and Challenges for Analytical Chemistry in the Assessment of Medication Adherence. First Ed","first-page":"13","author":"Tanna","year":"2016"},{"issue":"3\u20134","key":"10.1016\/j.talanta.2025.129293_bib12","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jchromb.2010.12.007","article-title":"Development of an LC-MS\/MS method for the quantitation of 55 compounds prescribed in combined cardiovascular therapy","volume":"879","author":"Gonzalez","year":"2011","journal-title":"J. Chromatogr., B: Anal. Technol. Biomed. Life Sci."},{"issue":"28","key":"10.1016\/j.talanta.2025.129293_bib13","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1016\/j.jchromb.2010.07.026","article-title":"LC-MS\/MS method for the determination of several drugs used in combined cardiovascular therapy in human plasma","volume":"878","author":"Gonzalez","year":"2010","journal-title":"J. Chromatogr., B: Anal. Technol. Biomed. Life Sci."},{"issue":"1","key":"10.1016\/j.talanta.2025.129293_bib14","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/FTD.0000000000001145","article-title":"Sample matrices for mass spectrometry-based adherence monitoring: a systematic critical review","volume":"46","author":"Jacobs","year":"2024","journal-title":"Ther. Drug Monit."},{"issue":"21","key":"10.1016\/j.talanta.2025.129293_bib15","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.4155\/bio.14.189","article-title":"Dried blood spot analysis to assess medication adherence and to inform personalization of treatment","volume":"6","author":"Tanna","year":"2014","journal-title":"Bioanalysis"},{"key":"10.1016\/j.talanta.2025.129293_bib16","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jpba.2017.04.045","article-title":"Quantitative LC\u2013HRMS determination of selected cardiovascular drugs, in dried blood spots, as an indicator of adherence to medication","volume":"142","author":"Bernieh","year":"2017","journal-title":"J. Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.talanta.2025.129293_bib17","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jpba.2013.04.002","article-title":"Bisoprolol, ramipril and simvastatin determination in dried blood spot samples using LC-HRMS for assessing medication adherence","volume":"81\u201382","author":"Lawson","year":"2013","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"1","key":"10.1016\/j.talanta.2025.129293_bib18","article-title":"The use of dried blood spots for the quantification of antihypertensive drugs","volume":"2018","author":"Chernonosov","year":"2018","journal-title":"Int. J. Anal. Chem."},{"issue":"16","key":"10.1016\/j.talanta.2025.129293_bib19","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.4155\/bio.13.156","article-title":"Hemato-critical issues in quantitative analysis of dried blood spots: challenges and solutions","volume":"5","author":"De Kesel","year":"2013","journal-title":"Bioanalysis"},{"issue":"6","key":"10.1016\/j.talanta.2025.129293_bib20","doi-asserted-by":"crossref","first-page":"653","DOI":"10.4155\/bio.14.310","article-title":"A device for dried blood microsampling in quantitative bioanalysis: overcoming the issues associated blood hematocrit","volume":"7","author":"Spooner","year":"2015","journal-title":"Bioanalysis"},{"issue":"21","key":"10.1016\/j.talanta.2025.129293_bib21","doi-asserted-by":"crossref","first-page":"12893","DOI":"10.1021\/acs.analchem.8b03512","article-title":"Evaluation of the Capitainer-B microfluidic device as a new hematocrit-independent alternative for dried blood spot collection","volume":"90","author":"Velghe","year":"2018","journal-title":"Anal. Chem."},{"issue":"4","key":"10.1016\/j.talanta.2025.129293_bib22","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/FTD.0000000000001175","article-title":"Analytical validation of a volumetric absorptive microsampling method for therapeutic drug monitoring of the oral targeted anticancer agents, abiraterone, alectinib, cabozantinib, imatinib, olaparib, and sunitinib, and metabolites","volume":"46","author":"Meertens","year":"2024","journal-title":"Ther. Drug Monit."},{"issue":"6","key":"10.1016\/j.talanta.2025.129293_bib23","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1007\/s43440-024-00663-9","article-title":"Personalization of pharmacotherapy with sirolimus based on volumetric absorptive microsampling (VAMS) in pediatric renal transplant recipients-from LC-MS\/MS method validation to clinical application","volume":"76","author":"Kocur","year":"2024","journal-title":"Pharmacol. Rep."},{"issue":"2","key":"10.1016\/j.talanta.2025.129293_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/metabo13020146","article-title":"VAMS-Based blood capillary sampling for mass spectrometry-based human metabolomics studies","volume":"13","author":"Volani","year":"2023","journal-title":"Metabolites"},{"issue":"6","key":"10.1016\/j.talanta.2025.129293_bib25","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1007\/s00216-020-03143-0","article-title":"Development, validation, and application of a quantitative volumetric absorptive microsampling-based method in finger prick blood by means of LC-HRMS\/MS applicable for adherence monitoring of antipsychotics","volume":"413","author":"Jacobs","year":"2021","journal-title":"Anal. Bioanal. Chem."},{"issue":"16","key":"10.1016\/j.talanta.2025.129293_bib26","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.4155\/bio.15.134","article-title":"A disposable sampling device to collect volume-measured DBS directly from A fingerprick onto DBS paper","volume":"7","author":"Lenk","year":"2015","journal-title":"Bioanalysis"},{"issue":"1","key":"10.1016\/j.talanta.2025.129293_bib27","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s43856-024-00480-4","article-title":"Proteome profiling of home-sampled dried blood spots reveals proteins of SARS-CoV-2 infections","volume":"4","author":"Fredolini","year":"2024","journal-title":"Commun. Med."},{"key":"10.1016\/j.talanta.2025.129293_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2025.128018","article-title":"Quantitative dried blood spot microsampling for therapeutic drug monitoring of -antiseizure medications by design of experiment and UHPLC-MS\/MS","volume":"293","author":"Cancellerini","year":"2025","journal-title":"Talanta"},{"issue":"9","key":"10.1016\/j.talanta.2025.129293_bib29","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1007\/s00216-025-05760-z","article-title":"Pre-analytic assessment of dried blood and dried plasma spots: integration in mass spectrometry\u2013based metabolomics and lipidomics workflow","volume":"417","author":"Bossi","year":"2025","journal-title":"Anal. Bioanal. Chem."},{"issue":"4","key":"10.1016\/j.talanta.2025.129293_bib30","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/FTD.0000000000000643","article-title":"Official International Association for Therapeutic Drug monitoring and clinical toxicology guideline: development and validation of dried blood spot-based methods for therapeutic drug monitoring","volume":"41","author":"Capiau","year":"2019","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.talanta.2025.129293_bib31","series-title":"ICH Guideline M10 on Bioanalytical Method Validation and Study Sample Analysis","year":"2022"},{"issue":"16","key":"10.1016\/j.talanta.2025.129293_bib32","doi-asserted-by":"crossref","first-page":"8489","DOI":"10.1021\/ac5022562","article-title":"Volumetric absorptive microsampling: a dried sample collection technique for quantitative bioanalysis","volume":"86","author":"Denniff","year":"2014","journal-title":"Anal. Chem."},{"issue":"2","key":"10.1016\/j.talanta.2025.129293_bib33","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3390\/antibiotics12020199","article-title":"A validated UHPLC-MS\/MS method to quantify eight antibiotics in quantitative dried blood spots in support of pharmacokinetic studies in neonates","volume":"12","author":"Liu","year":"2023","journal-title":"Antibiotics"},{"issue":"7","key":"10.1016\/j.talanta.2025.129293_bib34","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1002\/rcm.4459","volume":"24","author":"Remane","year":"2010","journal-title":"Rapid Commun. Mass Spectrom."},{"issue":"12","key":"10.1016\/j.talanta.2025.129293_bib35","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1007\/s00216-024-05244-6","article-title":"Towards clinical adherence monitoring of oral endocrine breast cancer therapies by LC-HRMS-method development, validation, comparison of four sample matrices, and proof of concept","volume":"416","author":"Jacobs","year":"2024","journal-title":"Anal. Bioanal. Chem."},{"issue":"3","key":"10.1016\/j.talanta.2025.129293_bib36","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.jpba.2006.09.030","article-title":"Direct quantification in bioanalytical LC-MS\/MS using internal calibration via analyte\/stable isotope ratio","volume":"43","author":"Nilsson","year":"2007","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"5","key":"10.1016\/j.talanta.2025.129293_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26051495","article-title":"Assessing adherence to antihypertensive medication by means of dose-dependent reference plasma concentration ranges and ultra-high performance liquid chromatography-ion trap mass spectrometry analysis","volume":"26","author":"Wagmann","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.talanta.2025.129293_bib38","series-title":"Disposition of Toxic Drugs and Chemicals in Man","author":"Baselt","year":"2017"},{"issue":"4","key":"10.1016\/j.talanta.2025.129293_bib39","doi-asserted-by":"crossref","DOI":"10.1097\/FTD.0000000000000962","article-title":"Dose-related reference range as a tool in therapeutic drug monitoring","volume":"44","author":"Haen","year":"2022","journal-title":"Ther. Drug Monit."},{"issue":"12","key":"10.1016\/j.talanta.2025.129293_bib40","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1111\/hiv.13715","article-title":"Cardiovascular medication adherence testing in patients living with HIV: a single-centre observational study","volume":"25","author":"Nazareth","year":"2024","journal-title":"HIV Med."},{"issue":"5","key":"10.1016\/j.talanta.2025.129293_bib41","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1080\/08037051.2020.1763775","article-title":"Assessment of adherence to diuretics and beta-blockers by serum drug monitoring in comparison to urine analysis","volume":"29","author":"Ritscher","year":"2020","journal-title":"Blood Press."},{"issue":"21","key":"10.1016\/j.talanta.2025.129293_bib42","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1002\/rcm.4736","volume":"24","author":"Remane","year":"2010","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.talanta.2025.129293_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2025.128018","article-title":"Quantitative dried blood spot microsampling for therapeutic drug monitoring of -antiseizure medications by design of experiment and UHPLC-MS\/MS","volume":"293","author":"Cancellerini","year":"2025","journal-title":"Talanta"},{"key":"10.1016\/j.talanta.2025.129293_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.aca.2021.339137","article-title":"Evaluation and analytical applicability of a novel volumetric absorptive microsampling strategy for adherence monitoring of antihypertensive drugs by means of LC-HRMS\/MS","volume":"1187","author":"Jacobs","year":"2021","journal-title":"Anal. Chim. Acta"},{"issue":"3","key":"10.1016\/j.talanta.2025.129293_bib45","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/rcm.1790","article-title":"Stable isotopically labeled internal standards in quantitative bioanalysis using liquid chromatography\/mass spectrometry: necessity or not?","volume":"19","author":"Stokvis","year":"2005","journal-title":"Rapid Commun. Mass Spectrom."},{"issue":"9","key":"10.1016\/j.talanta.2025.129293_bib46","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1016\/j.xphs.2019.04.008","article-title":"The degradation chemistry of prasugrel hydrochloride: part 1\u2014Drug substance","volume":"108","author":"Baertschi","year":"2019","journal-title":"J. Pharmaceut. Sci."},{"issue":"7","key":"10.1016\/j.talanta.2025.129293_bib47","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1124\/dmd.106.014522","article-title":"The disposition of prasugrel, a novel thienopyridine, in humans","volume":"35","author":"Farid","year":"2007","journal-title":"Drug Metabol. Dispos."},{"issue":"6","key":"10.1016\/j.talanta.2025.129293_bib48","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/cpdd.291","article-title":"Comparison of capillary and venous plasma drug concentrations after repeated administration of risperidone, paliperidone, quetiapine, olanzapine, or aripiprazole","volume":"5","author":"Remmerie","year":"2016","journal-title":"Clin Pharmacol Drug Dev"},{"issue":"5","key":"10.1016\/j.talanta.2025.129293_bib49","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00093-24","article-title":"Comparison of lumefantrine, mefloquine, and piperaquine concentrations between capillary plasma and venous plasma samples in pregnant women with uncomplicated falciparum and vivax malaria","volume":"68","author":"Saito","year":"2024","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.talanta.2025.129293_bib50","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s13054-020-02915-5","article-title":"Revisited: therapeutic and toxic blood concentrations of more than 1100 drugs and other xenobiotics","volume":"24","author":"Schulz","year":"2020","journal-title":"Crit. Care"}],"container-title":["Talanta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039914025017849?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039914025017849?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T19:21:14Z","timestamp":1773948074000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039914025017849"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":49,"alternative-id":["S0039914025017849"],"URL":"https:\/\/doi.org\/10.1016\/j.talanta.2025.129293","relation":{},"ISSN":["0039-9140"],"issn-type":[{"value":"0039-9140","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Capillary blood microsampling and LC\u2013Orbitrap analysis for adherence monitoring of cardiovascular drugs: method development, cross-validation, and patient proof-of-concept using VAMS and Capitainer-B","name":"articletitle","label":"Article Title"},{"value":"Talanta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.talanta.2025.129293","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"129293"}}